Alyeska Investment Group
NGNE icon

Alyeska Investment Group’s Neurogene NGNE Stock Holding History

Alyeska Investment Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,437
Closed -$354K – 439
2019
Q4 		$354K Buy
+1,437
New +$143K ﹤0.01% 369
2018
Q2 		– Sell
-13,957
Closed -$3.93M – 502
2018
Q1 		$3.93M Sell
13,957
-171
-1% -$47.2K 0.03% 308
2017
Q4 		$3.32M Hold
14,128
– – 0.03% 286
2017
Q3 		$4.01M Buy
14,128
+252
+2% +$72.3K 0.03% 307
2017
Q2 		$3.9M Buy
13,876
+6,568
+90% +$1.88M 0.03% 300
2017
Q1 		$2.44M Sell
7,308
-6,410
-47% -$2.25M 0.02% 380
2016
Q4 		$4.53M Buy
13,718
+110
+0.8% +$29.6K 0.04% 331
2016
Q3 		$3.64M Buy
13,608
+7,709
+131% +$1.55M 0.03% 345
2016
Q2 		$781K Buy
5,899
+120
+2% +$19.1K 0.01% 394
2016
Q1 		$1.02M Buy
5,779
+1,379
+31% +$268K 0.01% 355
2015
Q4 		$1.1M Buy
4,400
+179
+4% +$47.1K 0.01% 337
2015
Q3 		$1.19M Sell
4,221
-697
-14% -$161K 0.01% 375
2015
Q2 		$683K Buy
4,918
+79
+2% +$12K 0.01% 433
2015
Q1 		$796K Sell
4,839
-255
-5% -$51.8K 0.01% 445
2014
Q4 		$764K Sell
5,094
-188
-4% -$26.8K 0.01% 417
2014
Q3 		$704K Sell
5,282
-250
-5% -$38.1K 0.01% 348
2014
Q2 		$1.04M Buy
5,532
+517
+10% +$99.7K 0.02% 349
2014
Q1 		$1.28M Buy
+5,015
New +$1.29M 0.04% 281

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Alyeska Investment Group's NGNE Position: Q1 2020 in Review

Alyeska Investment Group sold out of Neurogene (NGNE) in Q1 2020, closing a stake of 1,437 shares — an estimated $354K sold.

Alyeska Investment Group first reported a position in NGNE in Q1 2014 and held it in 18 quarters. The position peaked at $4.53M in Q4 2016. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2020.

  • Alyeska Investment Group reported no remaining Neurogene position as of Q1 2020 after selling out during the quarter.
  • Alyeska Investment Group sold 1,437 Neurogene shares in Q1 2020, an estimated $354K.
  • Alyeska Investment Group first reported a position in Neurogene in Q1 2014 and held it in 18 quarters.
  • Alyeska Investment Group's Neurogene position peaked at $4.53M in Q4 2016.
  • 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2020.

Based on Alyeska Investment Group's 13F filing for Q1 2020, filed 15 May 2020.